Pacira BioSciences, Inc. 82P.F Stock
Pacira BioSciences, Inc. Price Chart
Pacira BioSciences, Inc. 82P.F Financial and Trading Overview
| Pacira BioSciences, Inc. stock price | 27.4 EUR |
| Previous Close | 35.8 EUR |
| Open | 36.8 EUR |
| Bid | 36.6 EUR x 20000 |
| Ask | 37.2 EUR x 20000 |
| Day's Range | 36.8 - 36.8 EUR |
| 52 Week Range | 32.4 - 58 EUR |
| Volume | 75 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.79B EUR |
| Beta (5Y Monthly) | 0.761083 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 1.4 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 79 EUR |
82P.F Valuation Measures
| Enterprise Value | 1.99B EUR |
| Trailing P/E | N/A |
| Forward P/E | 9.411764 |
| PEG Ratio (5 yr expected) | 0.62 |
| Price/Sales (ttm) | 2.6823783 |
| Price/Book (mrq) | 2.2026694 |
| Enterprise Value/Revenue | 2.97 |
| Enterprise Value/EBITDA | 13.312 |
Trading Information
Pacira BioSciences, Inc. Stock Price History
| Beta (5Y Monthly) | 0.761083 |
| 52-Week Change | -31.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 58 EUR |
| 52 Week Low | 32.4 EUR |
| 50-Day Moving Average | 38 EUR |
| 200-Day Moving Average | 42.87 EUR |
82P.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 45.99M |
| Float | 45.44M |
| Short Ratio | N/A |
| % Held by Insiders | 1.10% |
| % Held by Institutions | 109.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.56% |
| Operating Margin (ttm) | 10.26% |
| Gross Margin | 57.84% |
| EBITDA Margin | 22.30% |
Management Effectiveness
| Return on Assets (ttm) | 2.51% |
| Return on Equity (ttm) | -1.41% |
Income Statement
| Revenue (ttm) | 669.17M EUR |
| Revenue Per Share (ttm) | 14.61 EUR |
| Quarterly Revenue Growth (yoy) | 1.50% |
| Gross Profit (ttm) | 393.23M EUR |
| EBITDA | 149.28M EUR |
| Net Income Avi to Common (ttm) | -10455000 EUR |
| Diluted EPS (ttm) | -0.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 174M EUR |
| Total Cash Per Share (mrq) | 3.78 EUR |
| Total Debt (mrq) | 625.16M EUR |
| Total Debt/Equity (mrq) | 81.4 EUR |
| Current Ratio (mrq) | 3.811 |
| Book Value Per Share (mrq) | 16.707 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 133.63M EUR |
| Levered Free Cash Flow (ttm) | 114.02M EUR |
Profile of Pacira BioSciences, Inc.
| Country | Germany |
| State | FL |
| City | Tampa |
| Address | 5401 West Kennedy Boulevard |
| ZIP | 33609 |
| Phone | 813 553 6680 |
| Website | https://www.pacira.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 715 |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Q&A For Pacira BioSciences, Inc. Stock
What is a current 82P.F stock price?
Pacira BioSciences, Inc. 82P.F stock price today per share is 27.4 EUR.
How to purchase Pacira BioSciences, Inc. stock?
You can buy 82P.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacira BioSciences, Inc.?
The stock symbol or ticker of Pacira BioSciences, Inc. is 82P.F.
Which industry does the Pacira BioSciences, Inc. company belong to?
The Pacira BioSciences, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Pacira BioSciences, Inc. have in circulation?
The max supply of Pacira BioSciences, Inc. shares is 47.08M.
What is Pacira BioSciences, Inc. Price to Earnings Ratio (PE Ratio)?
Pacira BioSciences, Inc. PE Ratio is 19.57142800 now.
What was Pacira BioSciences, Inc. earnings per share over the trailing 12 months (TTM)?
Pacira BioSciences, Inc. EPS is 1.4 EUR over the trailing 12 months.
Which sector does the Pacira BioSciences, Inc. company belong to?
The Pacira BioSciences, Inc. sector is Healthcare.